Litcius/Paper detail

Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Zhe Yang, Jingqi Sun, Li Zhuang, Haibo Mou, Shusen Zheng

2022Liver Transplantation20 citationsDOI

Topics & Concepts

MedicineLiver transplantationHepatocellular carcinomaTransplantationInternal medicineBevacizumabGeneral surgeryGastroenterologyChemotherapyHepatocellular Carcinoma Treatment and PrognosisViral-associated cancers and disordersCholangiocarcinoma and Gallbladder Cancer Studies
Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation | Litcius